Johnson & Johnson Investor Presentation — July 2020

Document content

July 16, 2020Cautionary Note on Forward -looking Statements

3This presentation contains “forward -looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regar ding, among other things: future

operating and financial performance, product development, market position and business strategy. The reader is cautioned not to rely on these forward -looking

statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate o r known or unknown risks or

uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. R isks and uncertainties include, but are not

limited to: risks related to the impact of the COVID -19 global pandemic, such as the scope and duration of the outbreak, governm ent actions and restrictive measures

implemented in response, material delays and cancellations of medical procedures, supply chain disruptions and other impacts to our business, or on our ability to

execute business continuity plans, as a result of the COVID -19 pandemic; economic factors, such as interest rate and currency ex change rate fluctuations; competition,

including technological advances, new products and patents attained by competitors; challenges inherent in new product resear ch and development, including

uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new and existing pr oducts; challenges to patents; the impact of

patent expirations; the ability of the company to successfully execute strategic plans; the impact of business combinations a nd divestitures; manufacturing difficulties or

delays, internally or within the supply chain; product efficacy or safety concerns resulting in product recalls or regulatory action; significant adverse litigation or